After reaching a multimillion-dollar settlement with drug companies in October that averted the first trial over the opioid crisis, lead plaintiffs lawyers are gearing up for the next trial: this time, against six pharmacies including Walgreens and CVS.

Ahead of that trial, the pharmacies, however, have revived concerns about judicial conduct in the opioid litigation.